medigraphic.com
SPANISH

Revista Cubana de Farmacia

ISSN 1561-2988 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 2

<< Back Next >>

Rev Cubana Farm 2022; 55 (2)

Inhibition of intestinal transit in albino mice by ethanolic extract of Senecio nutans Schultz-Bip leaves

Anaya GRB, Falconí OV, Castilla TN, Cóndor AR, Paredes EC, Cundia AO
Full text How to cite this article

Language: Spanish
References: 27
Page: 1-16
PDF size: 642.83 Kb.


Key words:

Senecio nutans Schultz-Bip, intestinal transit, activated charcoal, castor oil.

ABSTRACT

Introduction: In Peru, as in other developing countries, gastrointestinal disorders such as diarrhea and abdominal cramps are very common. The population usually uses medicinal plants as a solution because of their easy access and availability, but many of them lack scientific evidence to support their beneficial effects on health.
Objective: Evaluate the inhibitory effect of intestinal transit of ethanolic extract of Senecio nutans Schultz-Bip leaves in albino mice.
Methods: Phytochemical screening was performed as a preliminary test. The inhibitory effect was based on the in vivo model of intestinal transit, with activated charcoal as a marker of intestinal motility, and as an inducer of diarrhea it was used castor oil. Four groups of five male mice (Mus musculus) BALB/c were randomly formed. The first group without any treatment (control); the second with the standard loperamide 1 mg/kg; the other groups, plant extract at 100 mg/kg and 200 mg/kg.
Results: The phytochemical analysis showed a greater presence of flavonoids. Ethanolic extract from S. nutans Schultz-Bip leaves slowed the intestinal transit of activated charcoal in a dose-dependent manner of 100 mg/kg (33.58%) and 200 mg/kg (24.34%); the second dose was similar to standard loperamide which was 15.22% (p< 0.05).
Conclusions: It was demonstrated that the ethanolic extract of S. nutansSchultz-Bip delayed the intestinal transit, with a dependent dose by inhibition of intestinal motility in mice.


REFERENCES

  1. Mishra A, Seth A, Maurya SK. Therapeutic significance and pharmacological activities ofantidiarrheal medicinal plants mention in Ayurveda: A review. J Intercult Ethnopharmacol. 2016 [acceso 14/09/2021];5:290-307. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927135/

  2. World Health Organization (WHO). Enfermedades diarreicas. Geneva: WHO; 2017 [acceso09/09/2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/diarrhoealdisease

  3. Kelber O, Bauer R, Kubelka W. Phytotherapy in Functional Gastrointestinal Disorders. DigDis. 2018 [acceso 15/10/2021];35 (Suppl 1):36-42. DOI: 10.1159/000485489

  4. Kumar R, Sharma DR, Bairwa DrK, Roy R, Kumar A. Pharmacological review on naturalantidiarrhoel agents. Der Pharma Chemica. 2010 [acceso 12/12/2021];2(2):66-93. Disponibleen: https://n9.cl/5jy0f

  5. Hilal-Dandan R, Brunton L. Goodman & Gilman. Manual de farmacología y terapéutica. 2ºed. Colombia: McGraw-Hill Medical; 2015 [acceso 27/11/2021]. Disponible en:https://accessmedicina.mhmedical.com/content.aspx?bookid=1468§ionid=93495680

  6. Organización Mundial de la Salud. Estrategia de la OMS sobre medicina tradicional 2014-2023. Ginebra: OMS; 2013 [acceso 27/11/2021]. Disponible en:https://apps.who.int/iris/handle/10665/95008

  7. Bruneton J. Farmacognosia: Fitoquímica, Plantas Medicinales. 2º ed. Zaragoza: Acribia SA;2018 [acceso 30/12/2021]. Disponible en:https://tejadarossi.files.wordpress.com/2017/01/farmacognosia_bruneton.pdf

  8. Miranda M, Cuéllar A. Manual de prácticas de laboratorio. Farmacognosia y productosnaturales. Ciudad Habana: Universidad de La Habana; 2000 [acceso 15/12/2021]. p. 25-49,74-79. Disponible en: https://isbn.cloud/9789590717956/manual-de-practicas-delaboratorio-farmacognosia-y-productos-naturales/

  9. Beltrán H, Calvo J. Two new species of Senecio (Compositae, Senecioneae) from Peru.Phytotaxa. 2021 [acceso 09/09/2021];479:198-204. Disponible en:https://www.biotaxa.org/Phytotaxa/article/view/phytotaxa.479.2.6

  10. Cifuentes F, Paredes A, Palacios J, Muñoz F, Carvajal L, Nwokocha CR, et al.Hypotensive and antihypertensive effects of a hydroalcoholic extract from Senecio nutans Sch.Bip. (Compositae) in mice: Chronotropic and negative inotropic effect, a nifedipine-likeaction. J Ethnopharmacol. 2016 [acceso 09/10/2021];179:367-74. DOI:10.1016/j.jep.2015.12.048

  11. Paredes A, Palacios J, Quispe C, Nwokocha CR, Morales G, Kuzmicic J, et al.Hydroalcoholic extract and pure compounds from Senecio nutans Sch. Bip (Compositae)induce vasodilation in rat aorta through endothelium-dependent and independent mechanisms.J Ethnopharmacology. 2016 [acceso 06/09/2021];192:99-107. Disponible en:https://www.sciencedirect.com/science/article/pii/S0378874116304317

  12. Paredes A, Leyton Y, Riquelme C, Morales G. A plant from the altiplano of Northern ChileSenecio nutans inhibits the Vibrio cholerae pathogen. Springerplus. 2016 [acceso08/09/2021];5:1788. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063825/

  13. Gálvez CE, Jiménez CM, Gómez A de LA, Lizárraga EF, Sampietro DA. Chemicalcomposition and antifungal activity of essential oils from Senecio nutans, Senecio viridis,Tagetes terniflora and Aloysia gratissima against toxigenic Aspergillus and Fusarium species.Nat Prod Res. 2020 [acceso 06/09/2021];34:1442-5. Disponible en:https://pubmed.ncbi.nlm.nih.gov/30456990/

  14. Lizarraga E, Castro F, Fernández F, de Lampasona MP, Catalán CAN. Antioxidant, hemolytic and cytotoxic activities of Senecio species used in traditional medicine ofnorthwestern Argentina. Nat Prod Commun. 2012 [acceso 11/09/2021];7:607-8. Disponibleen: https://pubmed.ncbi.nlm.nih.gov/22799087/

  15. Diario Oficial El Peruano. Congreso de la República del Perú. Ley Nª 30013. 28 abr. 2013[acceso 08/12/2021]. Disponible en: https://busquedas.elperuano.pe/normaslegales/ley-dedemarcacion-y-organizacion-territorial-de-la-provinci-ley-n-30013-930765-1/

  16. 16.Mangas R, Gutiérrez Y, González A, Lizama R, Hernández R, Monzote L, et al. Chemicalstudy and biological potential of plant species that grow in Cuba. Anales de la Academia deCiencias de Cuba. 2021 [acceso 20/10/2021];11(1). Disponible en:http://revistaccuba.sld.cu/index.php/revacc/article/view/901/994

  17. Instituto Nacional de Salud (INS). Comité Ética para el uso de animales en Investigación.Resolución Jefatural N° 268-2017-J-OPE/INS; 2017 [acceso 20/10/2021]. Disponible en:https://web.ins.gob.pe/es/comites-del-ins/comite-institucional-de-etica-para-uso-deanimales-en-investigacion

  18. Yunes RA, Filho VC. Quimica de Produtos Naturais: novos farmacos e a modernafarmacognosia. 5th ed. Itajaí: Editora UNIVALI; 2016 [acceso 05/10/2021]. 319 p.

  19. Romero-Trujillo DJO, Frank-Márquez DN, Cervantes-Bustamante DR, Cadena-LeónDJF, Montijo-Barrios DE, Cázares-Méndez DJM, et al. Sistema nervioso entérico y motilidadgastrointestinal. Acta Pediatr Mex. 2012 [acceso 14/09/2021];33:207-14. Disponible en:https://www.redalyc.org/pdf/4236/423640338008.pdf

  20. Hernández-Sampieri, R, Mendoza C. (2018). Metodología de la investigación. Las rutascuantitativa, cualitativa y mixta. México: Mc Graw Hill Education, 2018. 714 p. [acceso30/10/2021]. Disponible en: https://virtual.cuautitlan.unam.mx/rudics/?p=2612

  21. Parra C, Soto E, León G, Salas CO, Heinrich M, Echiburú-Chau C. Nutritionalcomposition, antioxidant activity and isolation of scopoletin from Senecio nutans: support ofancestral and new uses. Nat Prod Res. 2018 [acceso 14/12/2021];32:719-22. Disponible en:https://pubmed.ncbi.nlm.nih.gov/28587480/

  22. Guyton A, Hall J. Tratado de fisiología médica. 13th Edition. España: Elsevier; 2016[acceso 11/11/2021]. 1168 p. Disponible en: https://www.elsevier.com/books/guyton-y-halltratado-de-fisiologia-medica/hall/978-84-9113-024-6

  23. Arasaradnam RP, Brown S, Forbes A, Fox MR, Hungin P, Kelman L, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rdedition. Gut. 2018 [acceso 19/10/2021];67(8):1380-99. Disponible en:https://pubmed.ncbi.nlm.nih.gov/29653941/

  24. Arévalo A, Arévalo D, Villarroel C, Fernández I, Espinoza G. Enfermedad intestinalinfecciosa (diarrea). Rev. Méd. La Paz. 2019 [acceso 25/11/2021];25(1):73-85. Disponible en:http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582019000100011&lng=es

  25. Ministerio de Salud. Semana Epidemiológica-del 06 al 12 de setiembre del 2020. Boletínepidemiológico del Perú. 2020 [acceso 11/09/2021];29(SE)-37. Disponible en:http://bvs.minsa.gob.pe/local/MINSA/5148.pdf

  26. Ritter J, Hower R, Henderson G, Kong Y, Macewan D, Rang H. Farmacología. 9.º ed.Colombia: Elsevier; 2020 [acceso 02/12/2021]. Disponible en: https://n9.cl/bwwgn

  27. Moreno M. Abordaje diagnóstico de la diarrea crónica. Acta GastroenterológicaLatinoamericana. 2020 [acceso 25/11/2021];50(4):69-73. Disponible:https://www.redalyc.org/journal/1993/199367756016/html/




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Farm. 2022;55